Related Experiment Video
Updated: Sep 25, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
A systematic review of adherence to anticoagulation regimens in pediatric patients
Kevin E Todd1,2, Meghan E McGrady1,3,4, Edith Starbuck5
1Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Insights
Pediatric anticoagulation nonadherence rates range widely (3-42%) and are linked to patient age and medication interactions. More research is needed on nonadherence impacts in children on blood thinners.
Area of Science:
- Pediatric Hematology
- Pharmacology
- Clinical Medicine
Background:
- Thromboembolic disease incidence is rising in pediatric populations.
- Anticoagulation therapy is crucial for treating and preventing these events in children.
- Limited data exist on anticoagulation nonadherence in pediatric patients compared to adults.
Purpose of the Study:
- To systematically review the rates, outcomes, and predictors of anticoagulation nonadherence in pediatric patients.
- To identify knowledge gaps in the current literature regarding pediatric anticoagulation adherence.
Main Methods:
- A systematic review of scientific literature was conducted.
- 17 studies meeting inclusion criteria were analyzed from an initial pool of 3581 articles.
- Studies primarily focused on pediatric patients with cardiac disease using vitamin K antagonists.
Main Results:
- Reported nonadherence rates varied significantly, from 3% to 42%, depending on study population, adherence definition, and measurement methods.
- Factors correlating with nonadherence included patient age, target international normalized ratio (INR), and the number of interacting medications.
- Data linking nonadherence to specific health outcomes in children were scarce, present in only two studies.
Conclusions:
- Pediatric anticoagulation nonadherence is a significant issue with a wide range of reported rates.
- Patient-specific factors and medication complexity are associated with nonadherence.
- Substantial knowledge gaps exist regarding the clinical outcomes of nonadherence in pediatric patients, necessitating further investigation.
Abstract:
Thromboembolic disease rates are increasing in pediatric patients. Anticoagulation is prescribed for treatment and prevention of thromboembolic disease. While nonadherence to anticoagulation regimens predicts poor health outcomes in adults, data in anticoagulated pediatric patients are limited. We systematically reviewed the rates, outcomes, and predictors of anticoagulation nonadherence in the pediatric population. Out of a total of 3581 unique articles identified for review, 17 studies met inclusion criteria. These studies primarily evaluated patients with cardiac disease treated with vitamin K antagonists. Overall nonadherence rates varied from 3% to 42%, based upon population, definition of adherence, and measurement strategy. Patient age, goal international normalized ratio (INR), and number of concurrent potentially interacting medications correlated with nonadherence. Data examining the relationship between nonadherence and health outcomes were included in only two studies. Limitations of current literature, as well as critical knowledge gaps that require future study, are discussed.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pre-Procedural Guidelines for Assessing Blood Pressure

